Entero Therapeutics, Inc. Cash Flow Reinvestment Rate
Entero Therapeutics, Inc. cash flow reinvestment rate. Entero Therapeutics, Inc. (ENTO) has a Cash Flow Reinvestment Rate of 0.00x as of June 2014, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $129.24. Explore Entero Therapeutics, Inc. cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Entero Therapeutics, Inc. (2013–2013)
Cash flow reinvestment rate of Entero Therapeutics, Inc. from 2013 to 2013. Historical reinvestment intensity for Entero Therapeutics, Inc. across 1 annual periods. Also explore how fast is Entero Therapeutics, Inc. growing its equity to track the company's year-over-year net asset growth rate.
Entero Therapeutics, Inc. Cash Flow Reinvestment Rate by Year (2013–2013)
Entero Therapeutics, Inc. cash flow reinvestment rate by year from 2013 to 2013. Year-by-year capital reinvestment analysis for Entero Therapeutics, Inc.. For the full cash flow conversion analysis, see Entero Therapeutics, Inc. (ENTO) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2013 | 0.00x | $0.00 | $56.55 | $0.00 | — |